Recently, some studies have reported the successful derivation of iPSCs from human AML cells, including from blasts presenting MLL fusions, suggesting that this approach can generate human-based preclinical models (64, 65, 102, 103). This evidence concerns the gene KMT2A and acute myeloid leukemia.